• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Prognostic messages for cerebral palsy developed from a systematic review of the literature

bys25qthea
March 31, 2013
in Neurology, Pediatrics
Reading Time: 3 mins read
Share on FacebookShare on Twitter

Image: PD/USNavy

Key findings:

  1. The evidence regarding co-occurring impairments in children with cerebral palsy was summarized into concise clinical prognostic messages for parents
  2. To name a few, 3 in 4 children were in pain, 1 in 2 had an intellectual disability, 1 in 3 could not walk, and 1 in 4 could not talk

Primer: Cerebral palsy occurs in approximately 0.3% of births, making it the most common physical disability in childhood. By definition, it describes a heterogenous group of non-progressive clinical symptoms involving motor and postural dysfunction causing activity limitation due to disturbances of the developing brain. Children with cerebral palsy often have other problems, including cognitive issues, swallowing concerns, and seizures. It is expected that parents of children with cerebral palsy will ask pediatricians about common prognostic information about these functional limitations. Research, however, has shown that parents of children with cerebral palsy are dissatisfied with clinicians’ communication of this information.

For further reading, please see the following articles:

  1. Mutch L, Alberman E, Hagberg B, et al. Cerebral palsy epidemiology: Where are we now and where are we going? Developmental Medicine & Child Neurology 1992;34(6):547-551.
  2. Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine & Child Neurology 1997;39(4):214-223.

This [systematic review] study: The objective of the study was to systematically review the evidence with regards to co-occurring impairments, diseases, and functional limitations in cerebral palsy. The goal was to ultimately develop concise and parent-friendly prognostic messages. A total of 30 observational studies met the inclusion criteria required for meta-analysis, with >97% of the studies being the highest level according to the Oxford 2011 Levels of Evidence. Limitations of the study include a lack of data from developing countries and publication bias of the available literature. The following prognostic messages were developed from the findings of the study:

  1. 3 in 4 were in pain;
  2. 1 in 2 had an intellectual disorder;
  3. 1 in 3 could not walk/had a behaviour disorder;
  4. 1 in 4 could not talk/had epilepsy/had bladder control problems;
  5. 1 in 5 dribbled/had a sleep disorder;
  6. 1 in 10 were blind;
  7. 1 in 15 were tube-fed; and
  8. 1 in 25 were deaf.

In sum: Succinct prognostic messages can indeed be communicated to parents about their children with cerebral palsy. Using this systematic review on the co-occurring impairments, diseases, and functional impairments of children with cerebral palsy, clinicians can provide evidence-based answers to parents’ common questions.

RELATED REPORTS

Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers

Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse

Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer

Cerebral palsy is a classic example of a disease that affects multiple domains of childhood development and understandably causes increased anxiety in parents. Additionally, although it is a non-progressive disease, it does not uniformly affect children the same way, and functional limitations may change throughout the course of their lifespan. As a means of improving the relationship between clinicians and their patients’ families, developing prognostic messages based on robust evidence may allow clinicians to more comfortably communicate this commonly sought out information.

Click to read in Pediatrics

Written by [GL] and [AC]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

The RACE-II trial: Lenient vs. strict rate-control in atrial fibrillation [Classics Series]

Next Post

Decreasing incidence of heart failure observed in Ontario, Canada

RelatedReports

USPSTF recommends chemoprevention for women at high risk for breast cancer
Surgery

Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers

September 4, 2026
Similar outcomes after supracervical vs. total hysterectomy
Surgery

Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse

September 4, 2026
Dacomitinib may be effective in EGFR-associated lung cancer
Oncology

Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer

September 4, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Next Post

Decreasing incidence of heart failure observed in Ontario, Canada

Classics Series, Landmark Trials in Medicine

The HOPE trial: Ramipril significantly reduces cardiovascular events in high-risk patients with normal ejection fractions [Classics Series]

Increased blood pressure variability during the subacute stage of ischemic stroke is associated with worsened functional outcomes at 3 months

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers
  • Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse
  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in